Kyowa brings ‘novel option’ to immune health market with Immuse Paraprobiotic

By Danielle Masterson contact

- Last updated on GMT

Getty Images / ParfonovaIuliia
Getty Images / ParfonovaIuliia

Related tags: Immunity, paraprobiotic, Pdc

Ingredient manufacturer Kyowa Hakko and parent company Kirin Holdings unveiled its novel dietary supplement ingredient Immuse to deliver what they call a new approach for broad range immune support.

Despite the teeming immune support field, the company said their science speaks for itself: “As an international health ingredients manufacturer, Kyowa Hakko and Kirin were confident, based on Immuse's unique mechanism of action and human trials, that the paraprobiotic would make an excellent fit into the growing immunity market.  As a standalone or into a mixed ingredient formulation, Immuse can easily be added to an existing portfolio of products or developed into a new line of products,”​ explained Elyse Lovett, MS, MBA, senior marketing manager at Kyowa Hakko USA.


Immuse, discovered by Kirin Holdings, a pioneer in fermentation technology, is said to act by activating plasmacytoid dendritic cells (pDC). pDC has been shown to activate pivotal cells such as NK, Killer-T, Helper-T, and B cells, providing broad range immune support.

The dietary supplement ingredient is a unique patented strain of Lactococcus lactis​ strain Plasma characterized as a heat-killed lactic acid bacteria (paraprobiotic) that functions to activate the immune system. 

Kirin Holdings said they have continued their research into Lactococcus​ Plasma since its discovery, including various experiments that suggest effective anti-viral defense mechanisms. 

Functional ingredients 

Immuse is already on market as a finished product in Japan, where it is sold in the form of gummies, tablets, yogurt, and functional beverages. The product can be found in a wide variety of applications including tablets, capsules and gummy formulations. 

The Immuse products will be the first and only products in Japan to display an immune-related function on the product. 

Lovett told NutraIngredients-USA that Kirin Holdings and Kirin Beverage recently launched six new products containing the  Lactococcus lactis​ strain Plasma. “These six Immuse-branded products that utilize ​Lactococcus lactis strain Plasma were registered as Foods with Functional Claims with Japan’s Consumer Affairs Agency (CAA). When registration is accepted by the CAA, labeling of “functional claims” (usually health benefits) on products becomes possible.” 

“We could not be more thrilled to integrate the immune support benefits of IMMUSE into the US market,” ​said Lovett. “With more consumers looking for ways to enhance their immune system and stay healthy throughout the year, we are confident that Immuse, backed by both Kirin Holdings and Kyowa Hakko, will open new doors for consumers desiring a novel option for brand range immune support.”


Related news

Show more

Related products

show more

Consumers want multi-benefit products

Consumers want multi-benefit products

Wellmune | 13-Jan-2021 | Technical / White Paper

Over the past five years, 40% of global launches of immune health vitamin, mineral and supplement products have touted botanical or herbal properties,...

Natural solution for Healthy Weight management

Natural solution for Healthy Weight management

BIONAP Srl | 23-Nov-2020 | Product Presentation

MOROSIL™ is a standardized solid extract obtained only from the juice of a unique cultivar of Moro red oranges (Citrus sinensis (L.) Osbeck). Moro is the...

It’s time for HRB – A lifelong health partner

It’s time for HRB – A lifelong health partner

Morinaga Milk Industry Co., Ltd. | 19-Nov-2020 | Technical / White Paper

Consumer awareness of the importance of choosing the right probiotics that possess extensive clinical efficacy to address fundamental health problems (e.g.,...

Related suppliers

Follow us


View more